Follow
Devon Lukow
Devon Lukow
PhD Candidate, Stony Brook University
Verified email at lukow.me
Title
Cited by
Cited by
Year
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
A Lin, CJ Giuliano, A Palladino, KM John, C Abramowicz, ML Yuan, ...
Science translational medicine 11 (509), eaaw8412, 2019
5782019
Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies
DA Lukow, EL Sausville, P Suri, NK Chunduri, A Wieland, J Leu, JC Smith, ...
Developmental cell 56 (17), 2427-2439. e4, 2021
1342021
Oncogene-like addiction to aneuploidy in human cancers
V Girish, AA Lakhani, SL Thompson, CM Scaduto, LM Brown, ...
Science 381 (6660), eadg4521, 2023
692023
Chromosomal instability and aneuploidy as causes of cancer drug resistance
DA Lukow, JM Sheltzer
Trends in Cancer 8 (1), 43-53, 2022
452022
The system can't perform the operation now. Try again later.
Articles 1–4